<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04246892</url>
  </required_header>
  <id_info>
    <org_study_id>2019PI225</org_study_id>
    <nct_id>NCT04246892</nct_id>
  </id_info>
  <brief_title>Impact of Alarm Reduction on Delirium in ICU</brief_title>
  <acronym>ALADIN</acronym>
  <official_title>Impact of Alarm Reduction on Delirium in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Delirium is an acute and fluctuating disturbance of consciousness and can occur in 80% of&#xD;
      critically ill patients. Delirium is more frequent in mecanically ventilated patients and is&#xD;
      associated with longer hospital stay, increased cognitive impairment and mortality. On the&#xD;
      occasion of the change of the monitors in the ICU ward, allowing a total withdrawal of alarms&#xD;
      in patients room, this study evaluates the prevalence of delirium before and after the alarm&#xD;
      withdrawal. During the first period the patients will be monitored as usual, and during the&#xD;
      second period patients will be monitored without alarms ringing in patients room. Delirium&#xD;
      will be screened with a validated, clinical tool.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 3, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>14 Days</target_duration>
  <primary_outcome>
    <measure>prevalence of delirium, according to a ICDSC score&gt;3</measure>
    <time_frame>at the end on the ICU stay, an average of 6 days</time_frame>
    <description>prevalence of delirium in each group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prevalence of sub-syndromic delirium in each group, according to a ICDSC score&lt;4 and absence of delirium</measure>
    <time_frame>at the end on the ICU stay, an average of 6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of mecanical ventilation (days)</measure>
    <time_frame>at the end on the ICU stay, an average of 6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of stay in ICU (days)</measure>
    <time_frame>at the end on the ICU stay, an average of 6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>in patients presenting a delirium, duration of delirium (days) defined by the number of days with a ICDSC score&gt;3</measure>
    <time_frame>at the end on the ICU stay, an average of 6 days</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">254</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>group before alarm withdrawal</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>groupe after alarm withdrawal</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        all patients admitted to ICU, and who meet inclusion criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age&gt;18 years, admission to ICU&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  length of stay in ICU&lt;24 hours, moribund patient, deafness, dementia, psychiatric&#xD;
             pathology, delirium at admission, acute neurological pathology at admission (stroke,&#xD;
             epilepsy, neuro-infection), hepatic encephalopathy, admission for cardiac arrest,&#xD;
             admission for voluntary drug intoxication, pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Lev VOLKOV</last_name>
    <role>Study Director</role>
    <affiliation>Central Hospital, Nancy, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lev VOLKOV, Dr</last_name>
    <phone>0383858585</phone>
    <email>l.volkov@chru-nancy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lev Volkov, Dr</last_name>
      <phone>0623942830</phone>
      <email>l.volkov@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 20, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>April 4, 2021</last_update_submitted>
  <last_update_submitted_qc>April 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Lev VOLKOV</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

